Safingol Clinical Trials

Paid Clinical Trials > Browse Categories > Medications / Interventions > Ss > Safingol

Safingol

All Categories Medications / Interventions » Ss » Safingol

Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies

Condition: Solid Tumor
Intervention: Drug: Fenretinide (4-HPR) plus Intravenous Safingol
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Not yet recruiting - verified August 2011

Main Menu

Clinical Trial Categories

Clinical Trial Locations

Sponsors/Recruiting

Join Clinical Trials

Patient Accounts| Sponsor Accounts | Paid Cliical Trials | Find Patients | Clinical Trail Jobs | Articles |Privacy Policy | Email Policy | Terms of Use | HIPPA |Contact Us | Sitemap
All information is pulled by the U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. Note: PaidClinicalTrials.org, paidclinicaltrials.org (Aunica Media llc) are resources that provide individuals with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free